A 70-year-old woman was hospitalized with pulmonary edema. An echocardiogram shows significant left ventricular systolic dysfunction. After 5 days of treatment in the hospital, her symptoms improved and she was discharged home on digoxin, enalapril, spironolactone, and metoprolol. She is examined in follow up 1 week later, although her pulmonary examination and chest radiograph still show crackles and mild congestive heart failure, respectively, her symptoms are markedly improved. Which one of the following medications can be safely stopped without compromising this patient's survival?
سؤال مجاني 1 من 10 اليوم · اشترك وكمّل بدون حد
اعرض الإجابة
الإجابة والشرح
ادخل لحسابك عشان نحفظ إجاباتك ونوريك أخطاءك.
الإجابة: D. Digoxin
In HFrEF, ACE inhibitors (enalapril), beta-blockers (metoprolol) and MRAs (spironolactone) all reduce mortality. Digoxin does not improve mortality - it only gives symptomatic relief (fewer hospitalisations) - so it is the drug that can be stopped without compromising survival.
ليش كل خيار صح أو غلط
-
A
ليش غلط
ACE inhibitors such as enalapril reduce mortality and prolong survival in HFrEF, so they should be continued.
✓ Step-Up To Medicine 6th (HF).pdf · p. 8 -
B
ليش غلط
Aldosterone antagonists (spironolactone) are the third step and improve mortality.
✓ (Y4)-(M B) HF.pdf · p. 5 -
C
ليش غلط
Beta-blockers (metoprolol) are the second step and improve mortality.
✓ (Y4)-(M B) HF.pdf · p. 5 -
D
ليش صح
Digoxin has not been shown to improve mortality; it only gives short-term symptomatic relief as a positive inotrope.
✓ Step-Up To Medicine 6th (HF).pdf · p. 8
- المصدر
- Step-Up To Medicine 6th (HF).pdf · p. 8
(Y4)-(M B) HF.pdf · p. 6 - المحاضرة
- Acute Pulmonary Oedema · Cardiology · Module B
- ظهر في
- Cardio bank